{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreido2iiimb4accp7wjccla4yjzar6oelae7jj5qpos5tyq3pwn6o5q",
    "uri": "at://did:plc:wwyqal4cnqhuwyacdj7rqq3n/app.bsky.feed.post/3mibw23q7z5x2"
  },
  "path": "/t/biomarker-evaluation-c-statistic-auc-and-alternatives/6956?page=3#post_44",
  "publishedAt": "2026-03-30T14:08:07.000Z",
  "site": "https://discourse.datamethods.org",
  "textContent": "thank you for this post. I have been reading about NRI, and I have found it very confusing. I dont really understand why AHA is justifying the use of NRI, which critically informs several of their recommendations in the new AHA lipid guidelines. I was unsure if it was perhaps some new or novel accepted statisticall approach to categorical or event rate NRI, but it seems a poor choice compared to alternatives.",
  "title": "Biomarker evaluation - c-statistic (AUC) and alternatives"
}